Abstract
LOSS of myelin from central or peripheral myelinated nerve fibres results in conduction delays, increased refractoriness and, above all, conduction block1,2. Conduction failure could result either because a demyelinated axon is electrically inexcitable, or because the limited current available from a normal node is insufficient to excite it. Because continuous conduction along demyelinated internodes has been observed3, it seems likely that demyelinated axons in general are able to conduct impulses, but that the impedance mismatch at the junction of normal and demyelinated axon usually prevents the realisation of this ability. In support of this, two factors have been shown to improve transmission in experimental demyelination and also, transiently, in multiple sclerosis patients: lowered calcium ion concentration4,5, which reduces the threshold for nerve excitation, and lowered temperature6,7, which prolongs the action potential and thereby increases the time integral of current available to depolarise and excite the demyelinated axon. To test the suggestion that a drug that specifically prolongs the action potential might prove useful in the therapy of demyelinating diseases8, we have compared the effects of temperature and a scorpion venom on transmission in single fibres through a demyelinating lesion in rat spinal roots.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McDonald, W. I. & Sears, T. A. Brain 93, 583–598 (1970).
Rasminsky, M. & Sears, T. A. J. Physiol., Lond. 227, 323–350 (1972).
Bostock, H. & Sears, T. A. J. Physiol., Lond. (in the press).
Davis, F. A. & Jacobson, S. J. Neurol. Neurosurg. Psychiat. 34, 551–561 (1971).
Becker, F. O., Michael, J. A. & Davis, F. A. Neurology 24, 601–607 (1974).
Rasminsky, M. Arch. Neurol. 28, 287–292 (1973).
Watson, C. W. New Engl. J. Med. 261, 1253–1259 (1959).
Schauf, C. L. & Davis, F. A. J. Neurol. Neurosurg. Psychiat. 37, 152–161 (1974).
Hille, B. J. gen. Physiol. 50, 1287–1302 (1967).
Schmidt, H. & Stampfli, R. Pflüger's Arch. geon. Physiol. 287, 311–325 (1966).
Koppenhofer, E. & Schmidt, H. Experientia 24, 41–42 (1968).
Adam, K. R., Schmidt, H., Stampfli, R. & Weiss, C. Br. J. Pharmac. 26, 666–677 (1966).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BOSTOCK, H., SHERRATT, R. & SEARS, T. Overcoming conduction failure in demyelinated nerve fibres by prolonging action potentials. Nature 274, 385–387 (1978). https://doi.org/10.1038/274385a0
Issue Date:
DOI: https://doi.org/10.1038/274385a0
This article is cited by
-
Remyelination therapies: a new direction and challenge in multiple sclerosis
Nature Reviews Drug Discovery (2017)
-
The PMP22 Gene and Its Related Diseases
Molecular Neurobiology (2013)
-
Potassium channel blockers as an effective treatment to restore impulse conduction in injured axons
Neuroscience Bulletin (2011)
-
Information processing in the axon
Nature Reviews Neuroscience (2004)
-
Effects of pyrethroid molecules on rat nerves in vitro: potential to reverse temperature‐sensitive conduction block of demyelinated peripheral axons
British Journal of Pharmacology (1998)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.